The Current Ratio as of September 2024 (TTM) for Iovance Biotherapeutics, Inc. (IOVA) is 5.15

According to Iovance Biotherapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 5.15. This represents a change of 22.77% compared to the average of 4.20 of the last 4 quarters.

Iovance Biotherapeutics, Inc. (IOVA) Historical Current Ratio (quarterly & annually)

How has IOVA Current Ratio performed in the past?

The mean historical Current Ratio of Iovance Biotherapeutics, Inc. over the last ten years is 20.63. The current 5.15 Current Ratio has changed 2.40% with respect to the historical average. Over the past ten years (40 quarters), IOVA's Current Ratio was at its highest in in the December 2015 quarter at 63.79. The Current Ratio was at its lowest in in the December 2023 quarter at 2.79.

Iovance Biotherapeutics, Inc. (IOVA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Iovance Biotherapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Iovance Biotherapeutics, Inc. (IOVA) Average Current Ratio

How has IOVA Current Ratio performed in the past?

The current Current Ratio of Iovance Biotherapeutics, Inc. (IOVA) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Iovance Biotherapeutics, Inc. (IOVA) Current Ratio vs. Peers

How is IOVA’s Current Ratio compared to its peers?

Iovance Biotherapeutics, Inc.’s Current Ratio is greater than PTC Therapeutics, Inc. (2.23), less than Krystal Biotech, Inc. (9.50), greater than Sarepta Therapeutics, Inc. (3.90), less than Madrigal Pharmaceuticals, Inc. (8.72), less than CureVac N.V. (0), greater than Apellis Pharmaceuticals, Inc. (2.29), greater than Mirati Therapeutics, Inc. (5.08), less than CohBar, Inc. (7.54), greater than Rain Therapeutics Inc. (4.16), less than Ocean Biomedical, Inc. (5.58), greater than Hepion Pharmaceuticals, Inc. (0.03), less than null (5.62),

Build a custom stock screener for Iovance Biotherapeutics, Inc. (IOVA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Iovance Biotherapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Iovance Biotherapeutics, Inc. (IOVA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Iovance Biotherapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.